Canadian Expert Patients in Health Technology Conference Nov 7 – 8, 2016: Day 2

1. Rebuilding
Trust
Lessons
from
PharmaDiplomacy
Becky
Buell
Partner,
Meteos
Ltd
8
November,
CEPHT
Conference,
Toronto

2. PharmaDiplomacy
Dialogue
Aims:
• IdenGfy
primary
sources
of
mistrust
and
their
causes
• Define
what
it
would
take
to
achieve
breakthrough
agreements
• Develop
new
mechanisms
for
collaboraGon

3. PharmaDiplomacy
Group
• Senior
execuGves
from
health
systems
in
the
EU
and
US
– NICE,
MEDEV,
RIZIV,
United
Health,
Geisinger
• MulG-­‐naGonal
pharmaceuGcal
companies
– GSK,
J&J,
Novo
Nordisk
• PaGent
groups;
bioethicists;
investors
and
health
system
experts

5. Pricing:
a
Focal
Point
of
Mistrust

6. Factors
Undermining
Trust
on
Pricing
• How
prices
are
determined
• Price
inflaGon
• Value
versus
affordability
• Cost
versus
efficiency
• FragmentaGon

7. PharmaDiplomacy
Principles
Available
at:
www.meteos.co.uk/
projects/
pharmadiplomacy/

8. The
Principles
• IdenGfy
issues
for
discussion
at
3
key
touch-­‐
points
Pre/During
Phase
II
Launch/Post-­‐Approval
On-­‐Market
Review
• Emphasise
value
of
ongoing
dialogue
• Rank
issues
for
discussion
by
difficulty
• Accommodate
difference
(systems,
payer
prioriGes
and
TAs)

10. Next
Steps
• DistribuGon
of
Principles
• Integrate
in
exisGng
processes
(companies,
payers)
• Apply
to
new
product
at
pre-­‐Phase
II
(2
companies)
• Engagement
with
regulators
(US)
• Tool
for
paGent
engagement
• Progress
review
–
2017
www.meteos.co.uk
@meteosfutures